Please complete the CAPTCHA to continue
@tesorx.com
✓
3 phones found area 909 and 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Will Robberts is listed as Life Science and Technology President/CFO/CBO/Board Member | Global business strategy, deal-shaping, finance, operations, & fundraising at Enable Biosciences, based in Carlsbad, California, United States. AeroLeads shows a work email signal at tesorx.com, phone signal with area code 909, 650, and a matched LinkedIn profile for Will Robberts.
Will Robberts previously worked as Chief Financial Officer at Enable Biosciences and Board Advisor at Exsegen Genomics. Will Robberts holds Masters Of Commerce (M.Com), Financial Management from University Of Johannesburg.
This section adds company-level context without repeating Will Robberts's masked contact details.
AeroLeads found 2 current-domain work email signals for Will Robberts. Compare company email patterns before reaching out.
International life sciences and technology finance executive and co-founder of two pharmaceutical companies with 20+ years of experience in global business strategy, fundraising, operations, turnarounds, exits, corporate finance, business development, licensing and M&A.
Listed skills include Mergers And Acquisitions, Strategy, Litigation Support, Management, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
South San Francisco, California, US
Board Member since May 2019 and CFO from April 2024. Enable is creating the next generation of ultra-sensitive and highly specific antibody detection predictive medicine based on co-Board member, Dr. Caroline Bertozzi's, 2022 Nobel Science Prize-winning "click-chemistry" research. Spun out of UC Berkeley and Stanford in 2016 it has partnered with Stanford.
Menlo Park, California, US
LIPAC is a clinical-stage oncology company developing next-gen cancer therapies for patients suffering from cancers in the bladder, peritoneal and thoracic cavities. Its lead candidate is entering Phase 2b studies in NMIBC with a pipeline that includes multiple orphan indications.Co-founded company and its parent organization, TesoRx Pharma.Raised private.
Menlo Park, CA, US
TesoRx is a specialty urology company developing an oral Testosterone therapy for treating androgen deficiency (low T). It's novel drug delivery technology is well suited to poorly soluble drugs (such as glucagon-like peptide-1 (GLP-1) receptor agonists) and has been validated in over 200 patients in clinical studies.Co-founded company and its subsidiary.
Atlanta, Georgia, US
One of the largest U.S. consolidators of litigation services, conducting 150K+ depositions annually and employing over 1,200 court reporters and staff in 35 offices worldwide via its roll-up strategy.Responsible for leading the deposition business with $300M+ P&L during the 2007/8 financial crisis and growing the business via a roll-up strategy of.
Toronto, ON, CA
Thomson Reuters is a $50 Billion+ public company and the world’s leading provider of news and information-based tools to professionals. Continued to lead LiveNote operations and the integration into Westlaw suite of litigation products and services. Launched court reporting professional service business.
Led LiveNote as President and CFO to become the most widely used litigation support software in the USA with an 80%+ market share among the top 200 law firms in the USA. Orchestrated the business turnaround by building a new team and operational structure, returning it to profitability, securing PE funding, drove sales, and acquired its main competitor.
Petaluma, CA, US
AccountMate Software was a subsidiary of Softline Holdings, a publicly listed Corporation that provided accounting and business software and services. Led operations and finance for Accountmate and Softline's holdings in the USA and Australia.
Toronto, ON, CA
Started career at KPMG and served in the audit and corporate finance teams in South Africa before joining the information, communications, and entertainment (ICE) corporate finance team in London.Responsible for managing private/public financings, reverse mergers, and other M&A transactions.
Quick answers generated from the profile data available on this page.
Will Robberts works for Enable Biosciences.
Will Robberts is listed as Life Science and Technology President/CFO/CBO/Board Member | Global business strategy, deal-shaping, finance, operations, & fundraising at Enable Biosciences.
AeroLeads has found 2 work email signals at @tesorx.com for Will Robberts at Enable Biosciences.
AeroLeads has found 3 phone signal(s) with area code 909, 650 for Will Robberts at Enable Biosciences.
Will Robberts is based in Carlsbad, California, United States while working with Enable Biosciences.
Will Robberts has worked for Enable Biosciences, Exsegen Genomics, Lipac Oncology, Tesorx Pharma, Llc, and Esquire Deposition Solutions, Llc.
You can use AeroLeads to view verified contact signals for Will Robberts at Enable Biosciences, including work email, phone, and LinkedIn data when available.
Will Robberts holds Masters Of Commerce (M.Com), Financial Management from University Of Johannesburg.
Will Robberts is listed with skills including Mergers And Acquisitions, Strategy, Litigation Support, Management, Litigation, Legal Assistance, Contract Negotiation, and Entrepreneurship.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts